Our future studies will address the above-mentioned limitations and explore the effective dose, route, and time of administration of MMP-12 shRNA expressing plasmids, which could offer significant neuronal protection after cerebral ischemia and reduce brain damage with improved long-term neurological recovery. This evidence concerns the gene MMP12 and Cerebral ischemia.